熱門資訊> 正文
Biodexa Pharmaceuticals申请1亿美元的灵活证券发行
2025-09-27 05:31
- Biodexa Pharmaceuticals (NASDAQ:BDRX) has filed a $100M shelf registration for future offerings of various securities.
- Securities may include ordinary shares ADS representing ordinary shares debt securities, warrants, rights, and units.
- Source: SEC filing
More on Biodexa Pharmaceuticals
- Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals
- Historical earnings data for Biodexa Pharmaceuticals
- Financial information for Biodexa Pharmaceuticals
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。